Cleared Traditional

K981048 - HYDRAGEL 6 CSF KIT

K981048 is an FDA 510(k) clearance for HYDRAGEL 6 CSF KIT, manufactured by Morax. The device is a Class 2 Immunology device with product code CFF cleared through the Traditional 510(k) pathway after a 201-day FDA review.

K981048 · Morax · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1998
Decision
201d
Days
Class 2
Risk

K981048 is an FDA 510(k) clearance for the HYDRAGEL 6 CSF KIT. Classified as Immunoelectrophoretic, Immunoglobulins, (g, A, M) (product code CFF), Class II - Special Controls.

Submitted by Morax (Chelsea, US). The FDA issued a Cleared decision on October 7, 1998 after a review of 201 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Morax devices

FDA 510(k) Submission Details - K981048

510(k) Number K981048 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 20, 1998
Decision Date October 07, 1998
Days to Decision 201 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d slower than avg
Panel avg: 105d · This submission: 201d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CFF Device Classification - Class 2, Special Controls

Product Code CFF Immunoelectrophoretic, Immunoglobulins, (g, A, M)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CFF Immunoelectrophoretic, Immunoglobulins, (g, A, M)

All 26
Devices cleared under the same product code (CFF) and FDA review panel - the closest regulatory comparables to K981048.
K-ASSAY IGM
K993323 · Kamiya Biomedical Co. · Nov 1999
K-ASSAY IGA
K993213 · Kamiya Biomedical Co. · Nov 1999
POLYSLIT IFE KIT
K990998 · Helena Laboratories · Jun 1999
SPIFE IFE-6
K973040 · Helena Laboratories · Jan 1998
HYDRAGEL IF, 6 IF, 12 IF PENTA KITS/HYDRAGEL IF, DOUBLE IF, 2 IF, & 4 IF KITS
K960669 · Morax · Jul 1996
N-ASSAY TIA IGG
K933972 · Crestat Diagnostics, Inc. · Mar 1994